Jun, 2010
News / Press Releases
Astellas Announces Oral Presentation of SGLT2 Inhibitor Detailing Safety and Efficacy in Patients with Type 2 Diabetes at the American Diabetes Association Meeting(pdf40 KB)
Read More
News / Press Releases
Allotment of Stock Acquisition Rights (pdf76 KB)
Read More
News / Press Releases
Application for Mirabegron (YM178), a Treatment for OAB, in Japan (pdf42 KB)
Read More
News / Press Releases
Astellas' Brazilian Affiliate Initiates Business Operations(pdf38 KB)
Read More
Mar, 2024
Feb, 2024
Nov, 2023
Sep, 2023
News / General News
Integrated Report 2023 is now available.
Read More
Mar, 2024
Feb, 2024
Oct, 2023
Sep, 2023
Nothing Found
Unfortunately, we weren't able to find a match for your search query. Please try again.
Nothing Found
Unfortunately, we weren't able to find a match.